Document:

EX-10.3

 Exhibit 10.3 

AMENDMENT NO. 1 TO THE AMENDED AND RESTATED EXECUTIVE 

EMPLOYMENT AGREEMENT 
 This Amendment
No. 1 (this “Amendment”) to the Amended and Restated Employment Agreement is entered into as of March 25, 2016 by and between Zillow, Inc. (the “Company”) and Errol Samuelson (“Executive”). 

WHEREAS, as of March 5, 2014, Executive and the Company entered into an Executive Employment Agreement (the “Original
Agreement”) regarding the employment of Executive by the Company as its Chief Industry Development Officer; 
 WHEREAS, as of
April 2, 2014, Executive and the Company entered into an Amended and Restated Executive Employment Agreement (the “Amended and Restated Agreement”); 

WHEREAS, Executive and the Company wish to amend Sections 2.3(b) and 2.3(c) of the Amended and Restated Agreement to provide that the Annual
Restricted Units (as defined in the Amended and Restated Agreement) granted in 2016 and thereafter shall represent the right to receive shares of the Company’s Class C capital stock on or following the applicable anniversary of Executive’s
first day of employment with the Company, such number of shares to be determined by dividing the number of Annual Restricted Units by the closing price of the Company’s Class C capital stock during regular session trading as of the trading date
immediately preceding the applicable vesting date of such Annual Restricted Units; and 
 WHEREAS, pursuant to Section 5 of the Amended
and Restated Agreement, Executive and the Company wish to amend Sections 2.3(b) and 2.3(c) of the Amended and Restated Agreement to read as set forth herein. 

NOW, THEREFORE, in consideration of the mutual covenants and promises described below, Sections 2.3(b) and 2.3(c) of the Amended and Restated
Agreement are hereby amended to read in their entirety, and Executive and the Company agree, as follows: 
 “(b) Annual
grant of 345,000 Restricted Units (“Annual Restricted Units”), whereby each Annual Restricted Unit has an initial value of one U.S. dollar (U.S. $1.00) as of the date of grant and represents the right to receive shares of the
Company’s Class C capital stock on or following the applicable anniversary of Executive’s first day of employment with the Company (such that the grant of Annual Restricted Units approved in 2014 shall vest on the one-year anniversary
of Executive’s first day of employment and subsequent grants of Annual Restricted Units shall vest on each successive anniversary of Executive’s first day of employment), such number of shares to be determined by dividing the number of
Annual Restricted Units by the closing price of the Company’s Class C capital stock during regular session trading as of the trading date immediately preceding the applicable vesting date of such Annual Restricted Units. Upon vesting, the
Annual Restricted Units will be settled in shares of Class C capital stock. The grant of Annual Restricted Units approved in 2014 will be subject to Executive’s employment on the grant date and, for each grant of Annual Restricted Units
approved thereafter, continued employment through the applicable grant date, and vesting of Annual Restricted Units will be subject to Executive’s continued employment on the applicable vesting date. 

 (c) All settlement of the Equity Awards in shares of Class A common stock or Class C capital
stock of the Company, as applicable, shall be subject to normal payroll taxes and withholding. The Annual Restricted Units and Initial RSUs shall be subject to the terms and conditions of the Company’s Amended and Restated 2011 Incentive Plan
or any successor plan thereto and shall be further subject to the terms of an Unit Grant Notice, Restricted Unit Agreement, Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement that shall be provided to Executive to evidence the
Annual Restricted Units and Initial RSUs.” 
 [Signature Page Follows] 

  
 2 

 IN WITNESS WHEREOF, the parties have executed and entered into this Amendment effective on the date first set
forth above. 
  

			
	ERROL SAMUELSON
	
	 /s/ ERROL SAMUELSON

	
	ZILLOW, INC.
		
	By	 	 /s/ SPENCER M. RASCOFF

	Its	 	Chief Executive Officer

  
 3EX-10.1

 Exhibit 10.1 

Medtronlc 
 Office of 

Chairman and Chief Executive Officer 
 710 Medtronic
Parkway N.E. 
 Minneapolis, MN 55432-5604 
 USA 

May 2, 2016 
 Karen Parkhill 

4406 Lively Lane 
 Dallas, Texas 75220 

Dear Karen, 
 It is with great pleasure that I extend this Offer
Letter for Employment (herein called “Offer Letter”) with Medtronic. 
  

	1.	Title 

 Executive Vice President and Chief Financial Officer, Medtronic 

You will serve as a member of the Medtronic Executive Committee, reporting to me. 

 

	2.	Employment Location 

 Your employment with Medtronic will be located at Medtronic’s
Operating Headquarters in Fridley, Minnesota. As a condition of employment, you will be required to relocate to the Twin Cities Metro area in Minnesota within 15 months of your employment start date. 

 

	3.	Employment Start Date 

 Your employment with Medtronic will commence on June 20,
2016 (herein called “Start Date”). 
  

	4.	Base Salary 

 Your annual base salary will be $750,000 US Dollars (USD), less applicable
withholdings and deductions, commencing upon your Start Date and paid in accordance with Medtronic’s standard U.S. payroll practices. 
  

	5.	Medtronic Incentive Plan (“MIP”) 

 You will be eligible to participate in MIP
beginning with Fiscal Year 2017. Your participation will begin on your Start Date with a target payout equal to 110% of your full-year annual base salary for Fiscal Year 2017. Your actual payout will be based on Medtronic’s performance against
the MIP performance goals for Fiscal Year 2017. 

  

			
	Page 1 of 5	  	Confidential

 Karen Parkhill Offer Letter of Employment, May 2, 2016 

 

	6.	Annual Long-Term Incentive Plan (LTIP) 

 You will be eligible to participate in
Medtronic’s Long-Term Incentive Plan (LTIP) beginning with Fiscal Year 2017. The total target grant date value of your Fiscal Year 2017 LTIP will be $3,000,000 USD and is comprised of the following components: 

 

	 	A.	Annual Long-Term Performance Plan (“LTPP”) 

 LTPP is granted annually
and currently has a three-fiscal year performance period after which the incentive is paid in cash based on Medtronic’s performance against long-term performance goals. Beginning with the FY2017 - FY2019 performance period, you will be eligible
to participate in LTPP. Your target annualized award will be $1,000,000 USD. Current performance measures used for LTPP are 1) Revenue Growth (50% of payout opportunity) and 2) Return on Invested Capital (50% of payout opportunity). Performance
measures for the FY2017 - FY2019 LTPP will be confirmed by the Compensation Committee at its June 2016 meeting. 
  

	 	B.	Annual Nonqualified Stock Option Grant 

 You will be eligible for annual stock
option award beginning with Fiscal Year 2017. The anticipated grant date is August 1, 2016. The current grant amount (aggregate exercise price) is $4,000,000 USD, with a targeted grant date value of $1,000,000 USD, as of the date of this
letter, and vests 25% per year beginning one year after the date of grant. All terms and conditions of the stock option award will be described in the stock option agreement that is delivered to you following the grant date. Your nonqualified
stock option awards are subject to approval by the Compensation Committee of the Board of Directors. 
  

	 	C.	Restricted Stock Unit Grant 

 Beginning Fiscal Year 2017, you will be eligible
for annual grants of restricted stock units. The Fiscal Year 2017 grant date would be August 1, 2016. The current grant date value is $1,000,000 USD and vests 100% on the third anniversary of the date of grant, provided that a minimum company
performance threshold is achieved. The performance threshold set for Fiscal Year 2016 is a 3% Cumulative Compound Annual Growth Rate for Diluted Earnings Per Share measured for FY2016 - FY2018. The Compensation Committee will establish the FY2017-
FY2019 performance threshold prior to the grant date. All terms and conditions of any restricted stock unit award will be described in the restricted stock unit agreement provided following the grant date. Annual restricted stock unit awards are
subject to approval by the Compensation Committee of the Board of Directors. 
  

	7.	One Time, New Hire Cash Bonus 

 You will receive a new hire cash bonus in the amount of
$1,000,000 total. $500,000, less applicable withholdings and deductions, is payable within 30 days of your Start Date. The remaining $500,000, less applicable withholding and deductions, is payable within six (6) months of your Start Date. Both
new hire cash payments are subject to Medtronic’s standard clawback policy. To receive the bonus, you must sign and return the agreement to repay bonus, including in your new hire packet. 

 

	8.	One-time, New Hire Restricted Stock Unit Grant 

 You will be granted a one-time,
restricted stock unit award with a grant date value of $4,400,000 USD, which is scheduled to be granted on your Start Date. The Restricted Stock Unit grant will vest 33 1/3% on the first anniversary of the grant date, 33 1/3% on the

  

			
	Page 2 of 5	  	Confidential

 Karen Parkhill Offer Letter of Employment, May 2, 2016 

 

 
second anniversary of the grant date, and the remaining 33 1/3% on the third anniversary of the grant date; and is subject to the attainment by the Company of $1.00 diluted EPS threshold for the
fiscal year ending prior to each vesting date. 
 The actual number of units for the restricted stock unit grant will be based on the grant
date value of $4,400,000 USD divided by the market closing price for Medtronic stock on the Start Date. All terms and conditions of the restricted stock unit award are described in the restricted stock unit grant agreement. 

 

	9.	Relocation Benefits 

 You will be provided full executive relocation benefits to support
your move from Dallas Texas to Twin Cities Metropolitan area in Minnesota. The relocation benefits apply to your primary residence in Dallas. You are also approved to commute from Dallas to Medtronic’s Operating Headquarters in Fridley,
Minnesota, for up to 15 months if that should be necessary. If you commute, Medtronic will provide a taxable commuter allowance in an amount to be determined if commuting is determined to be necessary. The gross taxable amount will be calculated so
that the after-tax payment provides coverage for the associated commuting costs. 
  

	10.	Employee Health and Welfare Benefits 

 You will be offered the same benefits as all other
U.S. employees of Medtronic, including any benefits commensurate with your job level, upon meeting eligibility requirements as provided for in the Plan documents. An overview of Medtronic’s Benefit Programs is attached. Enrollment.in
Medtronic’s Benefits, including Health, Wellness, and Retirement programs will occur during your on-boarding orientation. 
  

	11.	Business Allowance 

 In order to provide remuneration for business use of your personal
automobile, financial planning services, and other personal, job related expenses; you will be provided with an annual allowance of $24,000 (paid bi-weekly). 
  

	12.	Deferred Compensation Plan 

 You will be eligible to participate in the next calendar
year phase of Medtronic’s Capital Accumulation Plan (“CAP”), subject to the terms of the CAP, which provides for the opportunity to defer a portion of calendar year 2017 compensation. If desired, you may enroll in the 2017 CAP during
the annual enrollment period held in October 2016. 
  

	13.	Termination 

 Your employment with Medtronic is “at will” and may be terminated
at any time by Medtronic or by you. If your employment is terminated by the Company without Cause, as defined in the 2013 Stock Award and Incentive Plan, and contingent upon your signing and complying with a severance and release agreement, the
Company shall pay or provide you with 
  

	 	i.	An amount equal to the product of (A) two times (B) the sum of (1) your Base Salary in effect at the time of employment termination and (2) your annual Target MIP Incentive; 

 

	 	ii.	An amount equal to the product of (A) twenty four (24) and (B) the monthly premium for COBRA continuation coverage under the Company’s medical, dental and vision plans, payable in a lump sum on the
date sixty (60) days after the date of termination. 

  

			
	Page 3 of 5	  	Confidential

 Karen Parkhill Offer Letter of Employment, May 2, 2016 

 

	 	iii.	Subject to your continued payment of the full COBRA premiums, continued participation for two (2) years in all medical, dental and vision plans which cover you (and eligible dependents) upon the same terms and
conditions (except for the requirements of your continued employment) in effect for active employees of the Company; 

  

	 	iv.	Continued vesting of the One-Time, New Hire Restricted Stock Unit grant specified in section 8 of this Letter of Intent, subject to the terms and conditions of the grant agreement and the vesting provisions contained
therein. 

  

	14.	Change in Control 

 You will be eligible for Medtronic’s Section 16 Officer
Change in Control Policy, which accompanies this Offer Letter. 
  

	15.	Employee Agreement 

 The compensation and benefits provided in this Offer are contingent
on you signing the Medtronic Employee Agreement, which specifies certain employment terms and conditions. That agreement is provided to you with this Offer Letter. 
  

	16.	Stock Ownership Policy 

 Medtronic’s policy requires Section 16 Officers to
maintain Medtronic stock equal to three (3) times annual salary. Unless noted otherwise by an equity grant agreement, Officers must retain 50% of the after-tax shares following settlement of equity compensation awards, including stock option
exercises and restricted stock vesting, until the stock ownership requirement is met. All shares of Medtronic stock owned by you, including the after tax value of unexercised stock options and the after tax value of unvested restricted stock unit
awards, count towards satisfying the stock ownership guideline. 
  

	17.	Reasonable Accommodation (Americans with Disabilities Act) 

 Medtronic is committed to
providing reasonable accommodations so that all individuals may participate fully in their employment. If you need accommodations because of a medical condition, or a religious belief or practice, please discuss your request with Carol Surface,
Chief Human Resources Officer, who will work with you to evaluate accommodation options. 
  

	18.	Eligibility Documents 

 As required by federal law, Medtronic must verify that its
employees are eligible to work in the United States. On or before your first day of employment, you may be required to certify that you are a citizen of the U.S., a noncitizen national of the U.S., a lawful permanent resident, or an alien authorized
to work in the U.S. Medtronic would assist you with completing immigration authorization documents and procedures with the United States Government. 

  

			
	Page 4 of 5	  	Confidential

 Karen Parkhill Offer Letter of Employment, May 2, 2016 

 

	19.	Legal Fees 

 Medtronic agrees to provide you with full reimbursement of any legal fees
that you incur associated with legal review, counsel, or action taken in conjunction with your employment termination with Comerica, Inc., including review of documents, legal counsel associated with that review, and any legal action necessary
should Comerica, Inc. decide to cancel your vested and unpaid restricted stock unit shares. Medtronic will not reimburse legal fees associated with any matter other than legal review, counsel, or action directly associated with your employment
termination with Comerica to join Medtronic. 
  

	20.	Other General Provisions 

 Medtronic expects you to take reasonable steps to protect
proprietary information from your current employer and to abide by any other confidentiality and applicable non-solicitation agreements. 
 Karen, I am
pleased to extend this offer of employment with Medtronic. Please review and direct any questions to Carol Surface, Chief Human Resources Officer. To accept this offer of employment, please sign and date below, sign the Medtronic Employee Agreement
included with this offer, and return the two original documents to Carol Surface. 
 Best regards, 

 
 

 
 Omar lshrak 
 Chairman and
Chief Executive Officer 
 I, Karen Parkhill, accept this offer of employment as outlined above. 

 

			
	

	  	May 2, 2016
	Signature	  	Date

  

			
	Page 5 of 5	  	Confidential

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}]]